Mereo BioPharma (MREO) Change in Account Payables (2023 - 2026)
Mereo BioPharma (MREO) reported Change in Account Payables of $2.0 million for Q1 2026, up 440.61% year-over-year from $362000.0 in Q1 2025, and up 337.81% quarter-over-quarter from $447000.0 in Q4 2025.
Mereo BioPharma (MREO) Change in Account Payables (2023 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has 4 years of Change in Account Payables data on file, last reported at $2.0 million in Q1 2026.
- Change in Account Payables for Q1 2026 came in at $2.0 million, up 440.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $217000.0 (down 43.04% YoY), and the FY2025 annual result was -$1.4 million, down 1043.84% from the prior year.
- Change in Account Payables improved to $2.0 million in Q1 2026 per MREO's latest filing, from $447000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $2.0 million in Q1 2026 and troughed at -$2.3 million in Q2 2023.
- A 4-year average of -$41384.6 and a median of $241000.0 in 2024 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2025 and 2026: Change in Account Payables plunged 909.54% in 2025, then jumped 440.61% in 2026.
- A 4-year view of Change in Account Payables shows it stood at $987000.0 in 2023, then fell by 14.59% to $843000.0 in 2024, then slumped by 46.98% to $447000.0 in 2025, then soared by 337.81% to $2.0 million in 2026.
- Business Quant data shows MREO's Change in Account Payables at $2.0 million in Q1 2026, $447000.0 in Q4 2025, and -$236000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -9.42 Mn |
| 10 | Mereo BioPharma | 252.49 Mn | 252.49 Mn | - | 1.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.96 Mn |
| Mar 31, 2026 | 1.96 Mn |
| Dec 31, 2025 | 447,000.00 |
| Dec 31, 2025 | 447,000.00 |
| Sep 30, 2025 | -236,000.00 |
| Sep 30, 2025 | -236,000.00 |
| Jun 30, 2025 | -1.95 Mn |
| Jun 30, 2025 | -1.95 Mn |
| Mar 31, 2025 | 362,000.00 |
| Mar 31, 2025 | 362,000.00 |
| Dec 31, 2024 | 843,000.00 |
| Dec 31, 2024 | 843,000.00 |
| Sep 30, 2024 | -1.07 Mn |
| Sep 30, 2024 | -1.07 Mn |
| Jun 30, 2024 | 241,000.00 |
| Jun 30, 2024 | 241,000.00 |
| Mar 31, 2024 | 127,000.00 |
| Mar 31, 2024 | 127,000.00 |
| Dec 31, 2023 | 987,000.00 |
| Dec 31, 2023 | 987,000.00 |